Comparison of the Generic HIV Viral Load® assay with the Amplicor™ HIV-1 Monitor v1.5 and Nuclisens HIV-1 EasyQ® v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: The Kesho Bora preparatory study

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 253-257

  Rouet, François ^a   Foulongne, Vincent ^b   Viljoen, Johannes ^c   Steegen, Kim ^d   Becquart, Pierre ^b   Valéa, Diane ^a,b   Danaviah, Sivapragashini ^c   Segondy, Michel ^b   Verhofstede, Chris ^d   Van de Perre, Philippe ^b  

^a CENTRE MURAZ   (Burkina Faso)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

HIV 1 RNA quantitation; Non B subtypes; Sub Saharan Africa

Indexed keywords

VIRUS RNA;

ANALYTIC METHOD; ARTICLE; ASSAY; BURKINA FASO; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; KENYA; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT PARTICIPATION; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTH AFRICA; VIRUS CONCENTRATION; VIRUS LOAD; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION;

BURKINA FASO; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; STATISTICS AS TOPIC; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73249148437     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.10.005     Document Type: Article

References (26)

1. Amendola A., Bordi L., Angeletti C., ViscoComandini U., Abbate I., Cappiello G., Budabbus M.A., Eljhawi O.A., Mehabresh M.I., Girardi E., Antinori A., Ippolito G., and Capobianchi M.R. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J. Acquir. Immune Defic. Syndr. 31 (2002) 488-494
2. Antunes R., Figueiredo S., Bartolo I., Pinheiro M., Rosado L., Soares I., Lourenco H., and Taveira N. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J. Clin. Microbiol. 41 (2003) 3361-3367
3. Bland J.M., and Altman D.J. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346 (1995) 1085-1087
4. Calmy A., Ford N., Hirschel B., Reynolds S.J., Lynen L., Goemaere E., de la Vega F.G., Perrin L., and Rodriguez W. HIV viral load monitoring in resource-limited regions: optional or necessary?. Clin. Infect. Dis. 44 (2007) 128-134 (review)
5. Damond F., Roquebert B., Benard A., Collin G., Miceli M., Yéni P., Brun-Vezinet F., and Descamps D. HIV-1 plasma viral load discrepancies between the Roche Cobas Amplicor HIV-1 monitor v1.5 and Roche Cobas Ampliprep/Cobas TaqMan HIv-1 assays. J. Clin. Microbiol. 45 (2007) 3436-3438
6. Foulongne V., Montes B., Didelot Rousseau M.N., and Segondy M. Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma. J. Clin. Microbiol. 44 (2006) 2963-2966
7. Gampini S., Kania D., Valéa D., Fao P., Kagoné T., Zango A., Méda N., Van de Perre P., and Rouet F. Early diagnosis of paediatric HIV-1 infection among west-African breast-fed children using dried blood spots and a quantitative HIV-1 RNA assay. 5th International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment. Cape Town, South Africa, July 19-22, 2009 (2009) (Abstract WEPEB264)
8. Germer J.J., Bendel J.L., Dolenc C.A., Nelson S.R., Masters A.L., Gerads T.M., Mandrekar J.N., Mitchell P.S., and Yao J.D.C. Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR test, version 1.5, on clinical laboratory operations. J. Clin. Microbiol. 45 (2007) 3101-3104
9. Gordon M., De Oliveira T., Bishop K., Coovadia H.M., Madurai L., Engelbrecht S., Janse van Rensburg E., Mosam A., Smith A., and Cassol S. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. J. Virol. 77 (2003) 2587-2599
10. Gottesman B.S., Grosman Z., Lorber M., Levi I., Shitrit P., Mileguir F., Gottesman G., and Chowers M.Y. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J. Med. Virol. 73 (2004) 167-171
11. Gottesman B.S., Grossman Z., Lorber M., Levi I., Shitrit P., Katzir M., Shahar E., Gottesman G., and Chowers M. Comparative performance of the Amplicor HIV-1 Monitor assay versus NucliSens EasyQ in HIV subtype C-infected patients. J. Med. Virol. 78 (2006) 883-887
12. Gueudin M., Plantier J.C., Lemee V., Schmitt M.P., Chartier L., Bourlet T., Ruffault A., Damond F., Vray M., and Simon F. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44 (2007) 500-505
13. Holguin A., Lopez M., Molinero M., and Soriano V. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1. 2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol. 46 (2008) 2918-2923
14. Kesho Bora Study Group. Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to short-ARV prophylaxis to prevent mother-to-child transmission of HIV-1: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. 5th International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment. Cape Town, South Africa, July 19-22, 2009 (2009) (Abstract LBPEC01)
15. Koenig S.P., Kuritzkes D.R., Hirsch M.S., Leandre F., Mukherjee J.S., Farmer P.E., and del Rio C. Monitoring HIV treatment in developing countries. BMJ 332 (2006) 602-604 (review)
16. Pasquier C., Millot N., Njouom R., Sandres K., Cazabat M., Puel J., and Izopet J. HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J. Virol. Methods 94 (2001) 45-54
17. Peeters M., Toure-Kane C., and Nkengasong J. Genetic diversity of HIV in Africa: impact on diagnosis, vaccine development and trials. AIDS 17 (2003) 2547-2560 (review)
18. Pillay C., Bredell H., McIntyre J., Gray G., and Morris L. HIV-1 subtype C reverse transcriptase sequences from drug-naive pregnant women in South Africa. AIDS Res. Hum. Retrovirus 18 (2002) 605-610
19. Rouet F., Chaix M.L., Nerrienet E., Ngo-Giang-Huong N., Plantier J.C., Burgard M., Peeters M., Damond F., Ekouevi K.D., Msellati P., Ferradini L., Rukobo S., Maréchal V., Schvachsa N., Wakrim L., Rafalimanana C., Rakotoambinina B., Viard J.P., Seigneurin J.M., and Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction. J. Acquir. Immune Defic. Syndr. 45 (2007) 380-388
20. Rouet F., Menan H., Viljoen J., Ngo Giang Huong N., Mandaliya K., Valea D., Lien T.X., Danaviah S., Rousset D., Ganon A., and Nerrienet E. In-house HIV-1 RNA real-time reverse transcription PCR assays: principle, available tests and usefulness in developing countries. Exp. Rev. Mol. Diagn. 8 (2008) 635-650
21. Rouet F., and Rouzioux C. HIV-1 viral load testing cost in developing countries: what's new?. Expert Rev. Mol. Diagn. 7 (2007) 703-707
22. Steegen K., Luchters S., De Cabooter N., Reynaerts J., Mandaliya K., Plum J., Jaoko W., Verhofstede C., and Temmerman M. Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings. J. Virol. Methods 146 (2007) 178-187
23. Stevens W., Horsfield P., and Scott L.E. Evaluation of the performance of the automated NucliSENS easyMAG and EasyQ systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of human immunodeficiency virus load. J. Clin. Microbiol. 45 (2007) 1244-1249
24. Stevens W., Wiggill T., Horsfield P., Coetzee L., and Scott L.E. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. J. Virol. Methods 124 (2005) 105-110
25. Wang Y.C., Song A.J., Xu S.H., Li X.H., Chong H.H., Zhao C.Y., Nie J.H., and Zhang C.T. Impact of HIV-1 genetic diversity in China on the measurement of viral load. J. Med. Virol. 80 (2008) 1-8
26. World Health Organization, 2006. Towards universal access by 2010. How WHO is working with countries to scale-up HIV prevention, treatment, care and support. World Health Organization, Geneva. Available at: http://www.who.int/hiv/universalaccess2010/en/.